In an earlier report sesamol exhibited renoprotective effects in streptozotocin (STZ) induced diabetes in rats [45] as it modulated the release of profibrotic cytokines i.e. tissue growth factor-1 beta (TGF-β1). Here, TGFB1 is linked to diabetes mellitus.